GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kwality Pharmaceuticals Ltd (BOM:539997) » Definitions » Gross Profit

Kwality Pharmaceuticals (BOM:539997) Gross Profit : ₹1,609 Mil (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Kwality Pharmaceuticals Gross Profit?

Kwality Pharmaceuticals's gross profit for the three months ended in Sep. 2024 was ₹461 Mil. Kwality Pharmaceuticals's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was ₹1,609 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Kwality Pharmaceuticals's gross profit for the three months ended in Sep. 2024 was ₹461 Mil. Kwality Pharmaceuticals's Revenue for the three months ended in Sep. 2024 was ₹900 Mil. Therefore, Kwality Pharmaceuticals's Gross Margin % for the quarter that ended in Sep. 2024 was 51.18%.

Kwality Pharmaceuticals had a gross margin of 51.18% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 11 years, the highest Gross Margin % of Kwality Pharmaceuticals was 53.92%. The lowest was 22.59%. And the median was 30.66%.


Kwality Pharmaceuticals Gross Profit Historical Data

The historical data trend for Kwality Pharmaceuticals's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kwality Pharmaceuticals Gross Profit Chart

Kwality Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 488.64 906.80 2,459.92 1,316.06 1,436.99

Kwality Pharmaceuticals Quarterly Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 355.01 381.46 356.58 410.62 460.83

Competitive Comparison of Kwality Pharmaceuticals's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Kwality Pharmaceuticals's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kwality Pharmaceuticals's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kwality Pharmaceuticals's Gross Profit distribution charts can be found below:

* The bar in red indicates where Kwality Pharmaceuticals's Gross Profit falls into.



Kwality Pharmaceuticals Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Kwality Pharmaceuticals's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=3071.718 - 1634.725
=1,437

Kwality Pharmaceuticals's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=900.344 - 439.515
=461

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,609 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Kwality Pharmaceuticals's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=461 / 900.344
=51.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Kwality Pharmaceuticals  (BOM:539997) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Kwality Pharmaceuticals had a gross margin of 51.18% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Kwality Pharmaceuticals Gross Profit Related Terms

Thank you for viewing the detailed overview of Kwality Pharmaceuticals's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Kwality Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Majitha Road, Village Nagkalan, 6th Mile Stone, Amritsar, PB, IND, 143601
Kwality Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing finished pharmaceutical formulations in a dosage form. The company manufactures and exports pharmaceutical formulations in liquid orals, dry syrups, tablets, capsules, sterile powder for injections, and small-volume injectables.

Kwality Pharmaceuticals Headlines

No Headlines